AboutStandards
MOTS-C research peptide vial — OSYRIS Health
LONGEVITY

MOTS-C

$69.99

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded within the 12S rRNA of mitochondrial DNA. It is studied for its regulatory effects on metabolic homeostasis, cellular stress responses, and insulin sensitivity in preclinical models. MOTS-c is strictly intended for laboratory research use and not for human application.

Quantity10mg
FormulaC48H73NO13S
Mol. Weight1042.18 g/mol
PuritySee COA
Free shipping on orders over $200
Download Certificate of Analysis
About This Compound

Product Overview

MOTS-C (Mitochondrial Open Reading Frame of the Twelve S rRNA type-C) is a mitochondrial-derived peptide — one of a recently discovered class of signaling molecules encoded within the mitochondrial genome rather than the nuclear genome. It was first identified in 2015 by Dr. Changhan David Lee's laboratory at the University of Southern California, making it one of the newest entries in peptide research.

MOTS-C is a 16-amino-acid peptide that functions as a retrograde signal from mitochondria to the nucleus, influencing cellular metabolism and gene expression. Its discovery was significant because it challenged the traditional view of mitochondria as passive energy generators — instead revealing them as active signaling organelles that communicate with the rest of the cell through secreted peptides.

The compound has a molecular weight of 1042.18 g/mol and is studied primarily in the context of exercise physiology, metabolic regulation, and aging biology.

MOTS-C mitochondrial retrograde signaling research visualization — OSYRIS Health
Research Applications

Mechanism and Experimental Context

MOTS-C's most striking research finding is its connection to exercise metabolism. Studies by Lee et al. demonstrated that MOTS-C activates AMPK (AMP-activated protein kinase) — the same master metabolic regulator that is activated during physical exercise. AMPK activation triggers a cascade of metabolic changes including increased glucose uptake, enhanced fatty acid oxidation, and improved mitochondrial biogenesis.1

In mouse models, MOTS-C administration improved exercise capacity and prevented diet-induced obesity without changes in food intake. The compound has been described as an "exercise mimetic" — a molecule that activates some of the same metabolic pathways that exercise activates. Research published in Cell Metabolism showed that MOTS-C levels in skeletal muscle increase during exercise in both mice and humans, suggesting it plays a natural role in exercise-induced metabolic adaptation.2

MOTS-C has been studied in models of metabolic dysfunction. In high-fat-diet mouse models, MOTS-C treatment improved glucose tolerance, reduced insulin resistance, and prevented excessive weight gain. These effects were associated with increased AMPK phosphorylation and enhanced mitochondrial function in skeletal muscle.3

Research has also shown that circulating MOTS-C levels correlate with metabolic health markers in human observational studies — lower MOTS-C levels have been associated with insulin resistance and obesity in some cohorts, though causality has not been established.

As a mitochondrial-derived peptide, MOTS-C is studied in the context of mitochondrial dysfunction during aging. Research has shown that MOTS-C levels decline with age in human plasma, paralleling the decline in mitochondrial function that characterizes aging tissues. Studies in aged mouse models demonstrated that MOTS-C treatment improved physical performance, restored metabolic parameters, and enhanced mitochondrial function in skeletal muscle.4

Referenced Studies

Source Literature

[1]

Lee C, et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metabolism, 2015. PubMed: PMID 25738459

[2]

Reynolds JC, et al. "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis." Nature Communications, 2021. PubMed: PMID 33446649

[3]

Kim SJ, et al. "MOTS-c regulates metabolic homeostasis in skeletal muscle." Journal of the American Geriatrics Society, 2019.

[4]

Kim KH, et al. "Mitochondrial-derived peptides in aging and age-related diseases." Journal of Physiology, 2017.

Certificate of Analysis

Batch Documentation

Current published batch documentation is surfaced on-page whenever the provider exposes a public COA asset.

MOTS-C certificate of analysis

Frequently Asked Questions

Questions About MOTS-C

MOTS-C is a mitochondrial-derived peptide — a signaling molecule encoded in the mitochondrial genome. It was discovered in 2015 and is studied for its effects on exercise metabolism, glucose regulation, and aging biology.

They are encoded in mitochondrial DNA rather than nuclear DNA, and they function as signals from mitochondria to the rest of the cell. Their discovery changed how scientists view mitochondria — from passive energy generators to active signaling organelles.

AMPK is the cell's master energy sensor. When activated (by exercise, caloric restriction, or compounds like MOTS-C), it triggers metabolic adaptations including increased glucose uptake and fat oxidation. MOTS-C is studied as a potential AMPK activator.

MOTS-C activates some of the same pathways as exercise (notably AMPK), which is why it's sometimes described as an "exercise mimetic" in research. This does not mean it replaces exercise — it means it's a useful research tool for studying exercise-related metabolic pathways.

Both are studied in aging and metabolism, but through different mechanisms. NAD+ works through sirtuin activation and electron transport chain function. MOTS-C works through AMPK activation and mitochondria-to-nucleus signaling. They represent different approaches to studying cellular metabolism.

Store lyophilized MOTS-C at -20°C for long-term or 2-8°C for short-term. Protect from light and repeated freeze-thaw cycles.

Every batch is independently tested via HPLC and LC-MS. The COA is downloadable on this page.

MOTS-C was first described in 2015 by Dr. Changhan David Lee's laboratory at USC. It is one of the newest peptides in active research.

Every Batch Tested by an Independent Lab

We publish the Certificate of Analysis for every product. See our full testing process.

See Our Standards →

All products sold by OSYRIS Health are intended for laboratory research purposes only and are not for human or veterinary use. The information provided on this page describes published scientific research and does not constitute medical advice, diagnosis guidance, or a recommendation for any specific use. Always ensure compliance with local regulations.